Recurrence of hepatitis C virus (HCV) infection after liver transplantation (LT) is almost
universal. However, variables that hasten the progression of allograft injury have not been …

Background. Several interrelated host and hepatitis C virus (HCV) associated factors have
been proposed to explain the variable outcomes in HCV recurrence. Recent evidence …

Background. Despite recent advances in diagnosis and treatment, cytomegalovirus (CMV)
infection continues to be a common cause of morbidity in liver transplant (LT) recipients …

Background. The effect of preemptive therapy on indirect sequelae associated with
cytomegalovirus (CMV) in liver-transplant recipients has not been clearly delineated …

In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been
inconsistently associated with increased mortality in liver transplant (LT) recipients. A …

Recurrence of hepatitis C (HCV) following liver transplantation is common. Herpesvirus
reactivation following transplant may have an immunomodulatory effect resulting in …

Cytomegalovirus (CMV) hepatitis is described as the most frequent manifestation of CMV
tissue invasive disease after liver transplantation. Its correlation with HLA-matching, hepatic …

Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …

We investigated the effect of β-herpesviruses on allograft failure and mortality, hepatitis C
virus (HCV) replication, and liver histologic characteristics among 92 HCV-infected liver …

Hepatitis C virus (HCV)-related cirrhosis is now, by far, the most common indication for liver
transplantation in North America and Europe. Over one third of available liver allografts are …